Vascular Grafts Market Size To Reach $2.8 Billion By 2030

Vascular Grafts Market Growth & Trends      

The global vascular grafts market size is expected to reach USD 2.8 billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising number of dialysis procedures and prevalence of chronic kidney diseases, heart attacks, atherosclerotic heart diseases, and stroke is boosting the adoption of vascular grafts. Moreover, the rising demand for minimally invasive surgeries among the population is impelling the market growth.

Furthermore, the increasing medical applications and developments in intraoperative techniques are driving the market. Peripheral vascular disease affects more than 200 million people worldwide. This is anticipated to raise the demand for vascular grafts during the forecast period. The outbreak of COVID-19 had a negative impact on the market growth due to the deferrals in non-essential medical procedures. It also affected the sales and operation of companies.

In 2023, the endovascular stent-graft products segment dominated the market with a revenue share of 63.8% due to its increasing adoption in response to the rising cases of aortic aneurysms. According to the data published by CDC, in 2019, about 9,904 deaths were witnessed due to aortic aneurysms in the United States. An unhealthy lifestyle has raised the prevalence of cardiac diseases and renal disease, thereby impelling the market growth.

Additionally, the increasing geriatric population and rising disposable income coupled with healthcare expenditure in emerging countries is contributing to market growth in these regions. The peripheral vascular grafts segment is expected to grow at the fastest rate due to increasing use in peripheral artery bypass. Also, the rising cases of hardening of arteries is boosting the demand for peripheral vascular graft.

The cardiac aneurysm application segment held the majority share in 2023 owing to the rising cases of raised blood pressure, hyperglycemia, hypercholesterolemia, etc. Also, the rising geriatric population and increasing cases of atherosclerotic heart diseases among the population are impelling the market growth. Moreover, the shifting trend toward minimally invasive treatments has raised the adoption of minimally invasive vascular implants to treat cardiac aneurysms, thereby boosting the segment growth.

On the other hand, the vascular occlusion application segment is anticipated to witness the fastest growth rate due to the increasing prevalence of vascular occlusion disease and the availability of graft procedures. Moreover, the development of novel therapies to treat vascular occlusion is anticipated to drive the market during the forecast period.

As of 2023, the polytetrafluoroethylene raw material segment held the majority share in the market and is expected to witness the fastest growth rate during the forecast period. The growth is attributed to its capability of tolerating pressures and flows in large and medium arteries; moreover, it offers low degradation and infection risk.    

The key players offering innovative products that offer maximum protection and help reduce the pain is impelling the market growth. For instance, Biovic offers AVATAR PTFE Vascular Graft. It is developed using Humidity Resistant Technology and has porous microstructure on both internal and external surfaces to maximize tissue in-growth and healing response.

North America dominated the market in 2023 owing to the rising geriatric population and associated health diseases. Moreover, the well-developed healthcare infrastructure and rising adoption of products with technological advancement are propelling the market growth. Also, the increasing investments in research and development activities in the region are contributing to the market growth. On the other hand, MEA is expected to witness the fastest growth during the projection period due to rising cases of people suffering from cardiovascular diseases in the region.

 Request a free sample copy or view report summary: Vascular Grafts Market Report

Vascular Grafts Market Report Highlights

• The global market size is anticipated to reach USD 2.8 billion by 2030, owing to the increasing prevalence of cardiovascular disease and the shifting trend toward minimally invasive procedures

• The endovascular stent-grafts product segment dominated the market in 2023 owing to rising cases of aneurysms and increasing patient preference for endovascular stent-grafts

• The cardiac aneurysm application segment dominated the market in 2023 owing to the rising prevalence of cardiovascular diseases across the globe

• the Polytetrafluoroethylene raw material segment dominated the market in 2023 majorly due to the rising demand for engineered prosthetic products

• North America dominated the market in 2023 majorly due to the development of novel products, increasing R&D activities, and developed healthcare infrastructure

Vascular Grafts Market Segmentation

Grand View Research has segmented the global vascular grafts market based on product, application, raw material, and region:

Vascular Grafts Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hemodialysis Access Grafts

• Endovascular Stent Grafts

• Coronary Artery By-Pass Grafts

• Vascular Grafts for Aorta Disease

• Peripheral Vascular Grafts

Vascular Grafts Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiac Aneurysm

  • Endovascular Stent Graft

  • Vascular Graft

• Kidney Failure

• Vascular Occlusion

• Coronary Artery Disease

Vascular Grafts Raw Material Outlook (Revenue, USD Million, 2018 - 2030)

• Synthetic Vascular Grafts

  • Polytetrafluoroethylene (PTFE) Grafts

  • Polyester Grafts

  • Polyurethane Grafts

• Biological Vascular Grafts

  • Autografts

  • Allografts

  • Xenografts

• Hybrid Vascular Grafts

Vascular Grafts Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Vascular Grafts Market

• Medtronic

• Terumo Corporation

• LeMaitre Vascular, Inc.

• Getinge AB

• BD (Becton Dickinson)

• Abbott

• B. Braun Melsungen AG.

• Abbott

• W. L. Gore and Associates, Inc.

• MicroPort Scientific Corporation

• Endologix